Thursday, November 5, 2009

Second Wave Of Influenza H1N1 To Hit Thailand And Malaysia In Mid- November

BANGKOK, Nov. 4 Thailand's public health ministry Wednesday reported two more deaths from the A/H1N1 flu, which raised the death toll from the new flu to 184.

The two new victims occurred during a period of Oct. 18 to 31, the public health ministry said. Those, who have congenital diseases and are pregnant women, are the most risky groups, Thai News Agency reported.

Meanwhile, Paijit Warachit, public health permanent secretary, said the ministry has adjusted a system of viral drug management to ensure flu patients can access to the drug in time.

Also, the ministry has instructed every hospital to continue closely monitoring those, who develop the A/H1N1 flu-like symptoms, he said.



Earlier, The Public Health Ministry expects the second round of Type A (H1N1) influenza outbreak is expected to hit the country in the middle of this month but with less severity, public health permanent secretary Paijit Warachit said on Monday.

Mr Paijit said less severity of the flu is anticipated on the grounds that people have acquired enough knowledge and experience to cope with it.

Deputy Prime Minister Sanan Kachornprasart, chairman of the committee on prevention and control of H1N1 pandemic, said during April 28-Oct 24 this year H1N1 flu spread to all provinces and nearly all districts of the country.

It was believed 6 million Thai people had contracted the flu and developed immunity against it.

The death toll from the flu in Thailand was 182, 90 men and 92 women, most of them between 31-40 years of age. They constituted about 3 per cent of the death toll worldwide, Maj-Gen Sanan said.

Maj-Gen Sanan said stricter measures must be taken to cope with the second round of pandemic. The Disease Control Department has ordered a total of 5 million doses of H1N1 vaccine, he added.

On the distribution of the vaccine, priorities will be given to public health staff, pregnant women, people weighing more than 100 kilogrammes, people aged below six months and above 64 years, and those with brain problems.